Literature DB >> 33808004

The Environmental Spread of Aspergillus terreus in Tyrol, Austria.

Anna-Maria Dietl1, Roya Vahedi-Shahandashti1, Carmen Kandelbauer1, Bart Kraak2, Michaela Lackner1, Jos Houbraken2, Cornelia Lass-Flörl1.   

Abstract

Fungal infections due to Aspergillus species have become a major cause of morbidity and mortality among immunocompromised patients. At the Medical University of Innsbruck, A. terreus and related species are the second most common causative agents of aspergillosis. In this one-year study we collected environmental samples to investigate (i) the environmental distribution, (ii) the ecological niche of A. terreus in Tyrol, (iii) the genetic relatedness of environmental and clinical isolates and the correlation between those two groups of isolates, and (iv) the antifungal susceptibility patterns. A. terreus was present in 5.4% of 3845 environmental samples, with a significantly higher frequency during winter (6.8%) than summer (3.9%). An increased A. terreus abundance in Tyrol's Eastern part was detected which is in agreement with the proof of clinical cases. In total, 92% of environmental and 98% of clinical A. terreus isolates were amphotericin B resistant; 22.6% and 9.8% were resistant against posaconazole. Overall, 3.9% of clinical isolates were resistant against voriconazole. Short tandem repeat analysis identified three major genotypes persisting in Tyrol. Soil from agricultural cornfields seems to be an important source; the environmental frequency of A. terreus correlates with the high incidence of A. terreus infections in certain geographical areas.

Entities:  

Keywords:  Aspergillus terreus; airborne pathogen; amphotericin B; antifungal susceptibility testing; azole; environmental distribution; environmental exposure; epidemiology; genotyping; resistance; short tandem repeat; soil

Year:  2021        PMID: 33808004      PMCID: PMC7998223          DOI: 10.3390/microorganisms9030539

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  51 in total

1.  Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.

Authors:  I Oren; N Haddad; R Finkelstein; J M Rowe
Journal:  Am J Hematol       Date:  2001-04       Impact factor: 10.047

2.  Aspergillus terreus in a cystic fibrosis clinic: environmental distribution and patient colonization pattern.

Authors:  B Cimon; R Zouhair; F Symoens; J Carrère; D Chabasse; J-P Bouchara
Journal:  J Hosp Infect       Date:  2003-01       Impact factor: 3.926

3.  Molecular epidemiology of Aspergillus collected from cystic fibrosis patients.

Authors:  Raquel Sabino; Jose A G Ferreira; Richard B Moss; Joana Valente; Cristina Veríssimo; Elisabete Carolino; Karl V Clemons; Cassie Everson; Niaz Banaei; John Penner; David A Stevens
Journal:  J Cyst Fibros       Date:  2014-10-30       Impact factor: 5.482

4.  Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Authors:  A Espinel-Ingroff; A Fothergill; J Fuller; E Johnson; T Pelaez; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

5.  A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.

Authors:  B Risslegger; T Zoran; M Lackner; M Aigner; F Sánchez-Reus; A Rezusta; A Chowdhary; S J Taj-Aldeen; M C Arendrup; S Oliveri; D P Kontoyiannis; A Alastruey-Izquierdo; K Lagrou; G Lo Cascio; J F Meis; W Buzina; C Farina; M Drogari-Apiranthitou; A Grancini; A M Tortorano; B Willinger; A Hamprecht; E Johnson; L Klingspor; V Arsic-Arsenijevic; O A Cornely; J Meletiadis; W Prammer; V Tullio; J-J Vehreschild; L Trovato; R E Lewis; E Segal; P-M Rath; P Hamal; M Rodriguez-Iglesias; E Roilides; S Arikan-Akdagli; A Chakrabarti; A L Colombo; M S Fernández; M T Martin-Gomez; H Badali; G Petrikkos; N Klimko; S M Heimann; J Houbraken; O Uzun; M Edlinger; S de la Fuente; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2017-04-13       Impact factor: 8.067

6.  A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.

Authors:  G Blum; S Perkhofer; K Grif; A Mayr; G Kropshofer; D Nachbaur; R Kafka-Ritsch; M P Dierich; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2008-12       Impact factor: 8.067

7.  Aspergillus terreus, a pathogen capable of causing infective endocarditis, Pulmonary mycetoma, and allergic bronchopulmonary aspergillosis.

Authors:  M N Laham; J L Carpenter
Journal:  Am Rev Respir Dis       Date:  1982-06

Review 8.  Changing epidemiology of systemic fungal infections.

Authors:  M Richardson; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2008-05       Impact factor: 8.067

9.  Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.

Authors:  Jagpal Singh; Dagmar Rimek; Reinhard Kappe
Journal:  Mycoses       Date:  2006-03       Impact factor: 4.377

10.  Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis.

Authors:  P C Iwen; J C Davis; E C Reed; B A Winfield; S H Hinrichs
Journal:  Infect Control Hosp Epidemiol       Date:  1994-05       Impact factor: 3.254

View more
  3 in total

1.  COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.

Authors:  Nina Lackner; Claudius Thomé; Dietmar Öfner; Michael Joannidis; Timo Mayerhöfer; Rohit Arora; Eldina Samardzic; Wilfried Posch; Robert Breitkopf; Cornelia Lass-Flörl
Journal:  J Fungi (Basel)       Date:  2022-01-18

2.  Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?

Authors:  Roya Vahedi-Shahandashti; Anna-Maria Dietl; Ulrike Binder; Markus Nagl; Reinhard Würzner; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2022-03-07       Impact factor: 5.938

3.  Aspergillus and Health.

Authors:  Raquel Sabino
Journal:  Microorganisms       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.